LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
LLY
1,008.98
-0.15%↓
JNJ
201.79
-0.2%↓
ABBV
226.23
-1.07%↓
UNH
330.51
-0.85%↓
AZN
90.18
+0.23%↑
24h
Current
Min
2.75
Max
2.86
Recommendations | Buy |
|---|---|
12 Months Forecast | +290.91% upside |
Past performance is not a reliable indicator of future results.
1 Oct 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Read
10 Mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 Mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 Mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 10.75 USD 290.91%
High 17 USD
Low 4.5 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$